ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

1ORNBV Orion Corporation

38.31
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Orion Corporation BIT:1ORNBV Italy Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 38.31 36.14 38.55 0.00 08:59:55

Change in Orion Group Executive Management Board: change in Orion's group-level functions

22/03/2024 10:30am

GlobeNewswire Inc.


Orion (BIT:1ORNBV)
Historical Stock Chart


From Mar 2024 to Jun 2024

Click Here for more Orion Charts.
Change in Orion Group Executive Management Board: change in Orion's group-level functions

ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS 

22 MARCH 2024 at 12.30 EET

        Change in Orion Group Executive Management Board: change in Orion's group-level functions

The following change will take place in Orion's group-level functions: the Corporate Strategy and Program Management (CSPMO) unit will become part of the Finance and Corporate Business Development unit.

The change will strengthen the steering of the Group and create a more unified approach to support Orion's business operations. As a result of the change, SVP Virve Laitinen will step down from the Orion Executive Management Board and will report to the Chief Financial Officer of the Orion Group as a Head of CSPMO. The change will take effect as of 1 April 2024.

Orion Corporation

Liisa HurmePresident and CEO   Olli HuotariSVP, Corporate Functions 

                                                Contact person:Liisa Hurme, President and CEOtel. +358 50 966 2874liisa.hurme@orion.fi

Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Finlandhttp://www.orion.fi/en http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

1 Year Orion Chart

1 Year Orion Chart

1 Month Orion Chart

1 Month Orion Chart

Your Recent History

Delayed Upgrade Clock